Kyverna Therapeutics Alternatives & Competitors
12 companies similar to Kyverna Therapeutics — Harnessing the power of cell therapy in autoimmune disease.
Cabaletta Bio
Engineered T cell therapies designed for the treatment of patients with autoimmune disease...
Philadelphia, United Stat...
Aspen Neuroscience, Inc.
Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and...
La Jolla, United States
KeifeRx
KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...
Mclean, United States
Orca Bio
Transforming allogeneic cell therapy for patients with cancer and autoimmune diseases.
Menlo Park, United States
Track all Kyverna Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Vico Therapeutics
Our mission is simple… bring innovative RNA modulating therapies to patients with severe,...
Leiden, The Netherlands
Entelexo Biotherapeutics
Entelexo has created a novel platform technology for engineering exosomes as a new approac...
Irvine, United States
Fate Therapeutics Inc.
Transforming the lives of patients with autoimmune diseases and cancer.
San Diego, United States
Santa Ana Bio, Inc.
Precision medicines for serious immune mediated diseases.
Alameda, United States
Sitryx
Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therap...
Oxford, United Kingdom
Nkarta, Inc.
A New Way Forward for Autoimmune Disease
South San Francisco, Unit...
Noa Therapeutics
Noa Therapeutics is transforming the treatment of inflammatory barrier diseases.
Toronto, Canada
Immunocore
Science to Transform Lives
Abingdon, United Kingdom
About Kyverna Therapeutics
Harnessing the power of cell therapy in autoimmune disease.
Development of CAR T-cell therapies for autoimmune diseases, Clinical trials management, Patient-centric therapeutic solutions, Next-generation cell therapy pipeline
Patients with autoimmune diseases, Healthcare providers specializing in rheumatology and neurology, Clinical research organizations
Cell Therapy, Biopharmaceuticals, Autoimmune Diseases, CAR T-cell Therapy, CD19-targeting, Neuroimmunology, Stiff Person Syndrome, Generalized Myasthenia Gravis, Multiple Sclerosis, Rheumatoid Arthritis, T-cell Engineering, Synthetic Biology, Curative Treatments, B-cell-driven Diseases, Autologous Therapies
B2C, B2B, B2D
Product Sales, Service Fee, Licensing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Kyverna Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Kyverna Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.